Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bestian Medical is a Taiwan-based biotechnology company specializing in regenerative medicine and advanced cell therapies. The company operates state-of-the-art Good Tissue Practice (GTP) certified laboratories dedicated to the development and processing of mesenchymal stem cells (MSCs), natural killer (NK) cells, and dendritic cells (DCs). Bestian Medical focuses on treating oncology indications and degenerative conditions, such as osteoarthritis, through both proprietary research and clinical collaborations with major medical centers. Their business model encompasses cell storage, cell processing services, and the advancement of clinical-stage cell therapy candidates under Taiwan's regulatory framework for specific medical care techniques. The company aims to bridge the gap between laboratory research and clinical application to provide personalized regenerative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bestian Medical Center.